106 Chapter 5 A B Figure S6. Kaplan-Meier estimates of progression free survival based on [89Zr]Zr-DFO-durvalumab SUVpeak (A) and tumor-to-blood-ratios dichotomized at median value, after correcting for lesions <20mm
Made with FlippingBook
RkJQdWJsaXNoZXIy MTk4NDMw